13 July 2018
: Case report
A Case of Herpes Simplex Virus Type 1 (HSV-1) Encephalitis as a Possible Complication of Cosmetic Nasal Dermal Filler Injection
Unusual or unexpected effect of treatment
Ching Soong Khoo1ABCDEF*, Hui Jan Tan1CDF, Syazarina Sharis Osman2CEFDOI: 10.12659/AJCR.909883
Am J Case Rep 2018; 19:825-828
Abstract
BACKGROUND: Dermal fillers are increasingly used for medical and aesthetic purposes in clinical practice. Common complications following filler injections include bruising, itching, infections, allergic reactions, and tissue necrosis. This case is the first report of Herpes simplex virus type 1 (HSV-1) encephalitis as a possible complication of dermal filler injection.
CASE REPORT: A 27-year-old woman with no past medical history presented with altered mental state, headaches, and seizures. She had a nasal dermal filler injection for aesthetic purpose five weeks before her acute presentation. A diagnosis of HSV-1 encephalitis was made based on brain imaging with computed tomography and magnetic resonance imaging (MRI) findings that showed bilateral frontotemporal lobe hyperintensity. Analysis of her cerebrospinal fluid (CSF) confirmed the presence of HSV-1 DNA. Despite anti-viral treatment with acyclovir, she developed postencephalitic syndrome.
CONCLUSIONS: This case report highlights the possibility that among the complications of the use of cosmetic dermal fillers, the transmission of HSV-1 and the development of HSV-1 encephalitis should be recognized.
Keywords: acyclovir, Encephalitis, Herpes Simplex, Status epilepticus
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947693
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947911
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946435
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947160
Most Viewed Current Articles
21 Jun 2024 : Case report
100,331
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,693
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,172
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
24,938
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200